BCRX icon

BioCryst Pharmaceuticals
BCRX

Overview Fund Activity

258 hedge funds and large institutions have $1.26B invested in BioCryst Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 79 increasing their positions, 90 reducing their positions, and 32 closing their positions.

Holders
258
Holders Change
+2
Holders Change %
+0.78%
% of All Funds
3.44%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
35
Increased
79
Reduced
90
Closed
32
Calls
$12.1M
Puts
$8.5M
Net Calls
+$3.61M
Net Calls Change
-$2.58M

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$165M
2
EP
2
Eversept Partners
New York
$14.9M
3
BlackRock
3
BlackRock
New York
$166M
4
HIM
4
Hillsdale Investment Management
Ontario, Canada
$4.08M
5
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$3.98M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$954K
2
Nuveen Asset Management
2
Nuveen Asset Management
Illinois
$25.7M
3
State Street
3
State Street
Massachusetts
$56.4M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$5.85M
5
Goldman Sachs
5
Goldman Sachs
New York
$9.71M
Name Holding Trade Value Shares
Change 		Shares
Change %
PA
251
Parallel Advisors
California
$699 -$233 -31 -25%
WA
252
Whipplewood Advisors
Colorado
$541 +$541 +72 New
IA
253
IFP Advisors
Florida
$399 +$399 +53 New
HI
254
Harbour Investments
Wisconsin
$384 – – –
Optiver Holding
255
Optiver Holding
Netherlands
$368 +$368 +49 New
NA
256
NewEdge Advisors
Louisiana
$83 +$83 +11 New
SS
257
SBI Securities
Japan
$30 +$30 +4 New
CCM
258
Cutter Capital Management
New York
– -$6.07M -798,137 Closed
TD Asset Management
259
TD Asset Management
Ontario, Canada
– -$2.31M -302,724 Closed
Macquarie Group
260
Macquarie Group
Australia
– -$1.9M -249,495 Closed
EAM
261
Exome Asset Management
New York
– -$1.49M -196,500 Closed
CM
262
Crestline Management
Texas
– -$1.14M -149,785 Closed
CM
263
Capula Management
Cayman Islands
– -$860K -113,186 Closed
BBA
264
Baker Bros. Advisors
New York
– -$576K -75,778 Closed
ADIM
265
Alpha DNA Investment Management
Maryland
– -$448K -58,898 Closed
EC
266
EntryPoint Capital
New York
– -$409K -53,763 Closed
PCM
267
Prelude Capital Management
New York
– -$296K -38,900 Closed
GAM
268
Gotham Asset Management
New York
– -$296K -38,893 Closed
Marshall Wace
269
Marshall Wace
United Kingdom
– -$253K -33,257 Closed
BC
270
Bridgefront Capital
Texas
– -$252K -33,126 Closed
I
271
InceptionR
California
– -$242K -31,826 Closed
AIM
272
Aigen Investment Management
New York
– -$218K -28,661 Closed
Rockefeller Capital Management
273
Rockefeller Capital Management
New York
– -$201K -26,400 Closed
CFM
274
Catalyst Funds Management
Australia
– -$189K -24,900 Closed
HF
275
HRT Financial
New York
– -$152K -20,044 Closed
8 9 10
11
12